Card image cap

John Dingell's Public Statements on Issue: Drugs

Deceased

Current Issue:

Drugs

Speech Type

All Debate Executive Order Floor Speech Hearing Interview Issue Position Letter News Article Op-Ed Other Pledge Press Conference Press Release Social Media Speech Statement

Date Range

Keyword Search
Reset Search
Page 1 of 3
Date Title
05/07/2013 Dingell Statement on Prescription Drug "Track & Trace" Markup
06/20/2012 Food and Drug Administration Safety and Innovation Act
06/12/2012 Dingell, UM Professor Dr. Johnston To Discuss $7M Grants from HHS
05/30/2012 User Fee Bill Co-Authored by Dingell Passes House
01/01/2012 Issue Position: Food & Drug Protection
07/07/2011 Dingell: FDA Confirms Authorities and Funding Included in H.R. 1483 Will Help to Prevent Another Heparin-Like Event
06/16/2011 House Democratic Leaders Introduce Legislation to Save More than $100 Billion in Medicare Drug Costs
06/16/2011 House Democratic Leaders Introduce Legislation to Save More Than $100 Billion in Medicare Drug Costs
06/15/2011 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2012
04/12/2011 Dingell, Waxman, Pallone, & DeGette Introduce Drug Safety Enhancement Act
12/21/2010 FDA Food Safety Modernization Act
12/17/2010 Dingell, Waxman, Pallone, & Stupak Introduce Drug Safety Legislation
12/08/2010 Full-year Continuing Appropriations Act, 2011
09/20/2010 Waxman, Dingell, Pallone & Stupak Open Discussion on Potentially Historic Changes in Drug Safety Laws
08/27/2010 Statement on GAO'S Clinical Trials Report
05/27/2010 Dingell Stresses Need For Additional Drug Safety Authorities
07/30/2009 Providing for Consideration of H.R. 2749, Food Safety Enhancement Act of 2009
06/23/2009 Panel II Of A Hearing Of The Health Subcommittee Of The House Energy And Commerce Committee - Comprehensive Health Reform
06/12/2009 Dingell Praises ‘Family Smoking Prevention And Tobacco Control Act.'
06/11/2009 Hearing Of The Health Subcommittee Of The House Energy And Commerce Committee - Emerging Health Care Issues: Follow-On Biologic Drug Competition
05/01/2009 Hearing Of The Health Subcommittee Of The House Energy And Commerce Committee - The 2009 H1N1 Flu Outbreak And The United States Federal Response
07/17/2008 Dingell, Stupak Question Whether FDA Knowingly Allowed Potentially Unsafe & Ineffective Drugs into the U.S. Marketplace
05/01/2008 Panel I of a Hearing of the Health Subcommittee of the House Energy and Commerce Committee - Drug Safety Provisions of the Food and Drug Administration Globalization Act Discussion Draft Legislation
04/30/2008 Hearing of the Oversight and Investigations Subcommittee of the House Energy and Commerce Committee - The Heparin Disaster: Chinese Counterfeits and American Failures
04/22/2008 Panel I of a Hearing of the Oversight and Investigations Subcommittee of the House Energy and Commerce Committee - The Food and Drug Administration's Foreign Drug Inspection Program
Page 1 of 3
arrow_upward